Skip to content
To the full analysis

Phibro Animal Health stock: balance sheet and debt

PAHC
$35.46Closing price of 12 Nov 2026MEQIRI Score 57 out of 100

Phibro Animal Health has a debt to equity ratio of 2.05 and an interest coverage of 3.9x.

Daily figure as of 13 Nov 2026

Debt / Equity
2.05
Interest coverage
3.9x
Current ratio
2.96
Cash & equivalents
$81.99M
Total assets
$1.5B
Equity ratio
25.7%
Goodwill
$60.05M
Plus intangible assets of $30.05M
Net debt
$706.77M

Total assets and equity ratio

How large the balance sheet of Phibro Animal Health Corporation is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2007$271.9M$7.4Mnot split out−32.4%$228.6M
2008no datano datano datano data$0
2009no datano datano datano data$0
2010no datano datano datano data$0
2011no datano datano datano data$0
2012$440.91M$16.77M$1.72M−20.0%$296.22M
2013$474.14M$47.77M$12.61M−14.5%$338.24M
2014$472.32M$42.42M$12.61M3.2%$277.57M
2015$493.32M$49.89M$12.61M6.0%$260.3M
2016$610.37M$81.22M$21.12M14.8%$319.11M
2017$623.4M$78.58M$23.98M24.2%$257.06M
2018$671.68M$79.33M$27.35M27.5%$233.21M
2019$726.67M$74.83M$27.35M29.7%$244.6M
2020$784.1M$123.68M$52.68M24.0%$319.38M
2021$841.33M$114.96M$52.68M28.4%$333.49M
2022$931.7M$117.09M$53.23M28.2%$379.24M
2023$971.4M$108.26M$53.27M29.1%$428.69M
2024$982.18M$99.59M$54.56M26.1%$410.85M
2025$1.36B$96.11M$59.65M21.0%$684.51M
2026$1.5B$90.1M$60.05M25.7%$706.77M

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt. In years without separate goodwill, the table shows the sum of goodwill and intangible assets, because the data do not list goodwill separately there.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2007$12M−$88M$240.6M−2.73
2008$0$0$00
2009$0$0$00
2010$0$0$00
2011$0$0$00
2012$53.9M−$88.23M$350.12M−3.97
2013$27.37M−$68.94M$365.6M−5.3
2014$11.82M$15.15M$289.39M19.1
2015$29.22M$29.63M$289.52M9.77
2016$33.61M$90.48M$352.71M3.9
2017$56.08M$151.16M$313.14M2.07
2018$79.17M$184.95M$312.38M1.69
2019$81.57M$216.02M$326.18M1.51
2020$91.34M$188.2M$410.72M2.18
2021$93.21M$238.53M$426.71M1.79
2022$91.25M$262.44M$470.48M1.79
2023$81.28M$282.51M$509.97M1.81
2024$114.61M$256.64M$525.46M2.05
2025$77.04M$285.68M$761.55M2.67
2026$81.99M$385.48M$788.77M2.05

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2026, period end 30 Jun 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 6 Mar 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy